Eyedeal’s xPIB IOL Innovation Showcased in Nuremberg, Germany – Global Experts Recognize Potential of New Ocular Biomaterials

Recently, at the 36th International Congress of German Ophthalmic Surgery held in Nuremberg, Germany, a scientific breakthrough from Xi’an, China, sparked widespread discussion among attending experts about the future of innovative materials in ophthalmology.

Professor Gerd U. Auffarth—Director of the David J. Apple Laboratory, Chair of the Department of Ophthalmology at Heidelberg University, and a globally renowned cataract and intraocular lens (IOL) specialist—delivered a keynote presentation titled “Novel IOL Material – xPIB (Cross-linked Polyisobutylene) by a New Innovative Company – Eyedeal.”

Professor Auffarth has followed the research and development progress of Xi’an Eyedeal Medical Technology Co., Ltd. for several years, particularly their pioneering work in “cross-linked polyolefins” for IOL applications. In his speech, he offered a comprehensive overview of the development of cross-linked polyolefins, their material properties, and their performance in implantable medical devices, highlighting the impressive clinical potential of xPIB. He emphasized that xPIB’s unique material characteristics offer new possibilities in the treatment of cataracts and other ocular conditions.

Following the presentation, expert reviewers highly praised Eyedeal’s xPIB material and its next-generation intraocular lens technology. They recognized xPIB as a highly promising biomaterial, noting that its applications may extend well beyond ophthalmology—potentially impacting broader biomedical and medical fields.

To further gauge industry sentiment, event organizers conducted a live survey among attending scholars and professionals. When asked, “Do you believe this innovation will succeed?”, an overwhelming 73% responded affirmatively. This result strongly affirms the potential of cross-linked polyolefin IOLs and reflects the global ophthalmology community’s recognition of Eyedeal’s contributions to innovation in the field.